The global smart syringes market is set for robust growth, with an estimated size of USD 1.05 billion in 2024 and a projection to reach USD 2.22 billion by 2033. This represents a ...
A viral video of a 6-year-old girl calmly injecting her own insulin has touched millions, with many praising her bravery, but ...
The Global Prefilled Syringes Market is entering a transformative era driven by biologics expansion, injectable ...
Despite its small base, rapid growth in smart insulin administration, connected devices, patient-centric care, and home-based ...
The use of injectable peptides for a range of perceived health benefits is surging, fueled by aggressive marketing campaigns and miraculous claims from celebrities and influencers about their ability ...
A research team led by scholars from Zhejiang University in East China has achieved the world's first non-invasive delivery ...
Novo Nordisk A/S is rated a Strong Buy with a huge unmet demand in obesity treatment and a low 13x P/E ratio. Learn more ...
Jacob will then review the financial results for the fourth quarter and full year 2025 and share our preliminary thoughts for ...
Chinese researchers recently achieved the world's first non-invasive insulin delivery through skin, resulting in a blood sugar-lowering effect comparable to regular insulin injections.
In mice with type 1 diabetes, a topical dose of OP-I was smeared onto the skin. Blood glucose levels fell to a normal range ...
A groundbreaking polymer-based skin cream shows promise in replacing painful daily insulin injections for diabetes management ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results